Vanderbilt University Medical Center: Heart Failure trials

The registry lists 12 Heart Failure studies with Vanderbilt University Medical Center as lead sponsor. 3 are open to participants now and 2 have results posted.

Phase 1 1Phase 2 1Phase 3 1Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne CardiomyopathyRecruitingNCT07172971Phase 1
• Wearable Technology to Evaluate Hyperglycemia and HRV in DMDRecruitingNCT06124196
• Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal AimRecruitingNCT06093100
• Efficacy and Safety of Dapagliflozin in Acute Heart FailureCompletedNCT04298229Phase 3Results posted
• Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2CompletedNCT04113109Phase 4Results posted
• Improving Diagnostic Accuracy for Acute Heart FailureCompletedNCT04886128
• Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)Active, not recruitingNCT04481919Phase 2
• Study for Breathing Interventions in Congestive Heart FailureWithdrawnNCT03449121Not applicable
• Peripheral Venous Analysis (PIVA) for Predicting Volume Responsiveness and Fluid StatusTerminatedNCT03407287
• Prospective Observation of Cardiac Safety With Proteasome InhibitionCompletedNCT02178579
• Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).CompletedNCT01977703Not applicable
• Effectiveness of a Walking Program Modulating Cardioreparative Factors in Heart FailureCompletedNCT00937443